Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget’s disease of bone

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 4, pp. 529-536

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2019

  1. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

    Endocrine, Vol. 64, Núm. 3, pp. 441-455

  2. Zoledronate in the prevention of Paget's (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone

    BMJ Open, Vol. 9, Núm. 9

2017

  1. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking

    Revista de Psiquiatria y Salud Mental, Vol. 10, Núm. 1, pp. 4-20

  2. Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics

    Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34

2010

  1. Análisis farmacoeconómico de Metoject® en el tratamiento de la artritis reumatoide en España

    Reumatologia Clinica, Vol. 6, Núm. 4, pp. 203-211

2004

  1. The quality of life in primary Sjogren's syndrome: SF-36 scales and patterns of disease expression.

    ARTHRITIS AND RHEUMATISM

1998

  1. Fisiopatología articular

    Fundamentos de fisiopatología (McGraw-Hill Interamericana de España), pp. 631-642